4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001695028-25-000004
Chief Financial Officer sold 11,000 shares at $14.52 ($159,719)
- Chief Financial Officer acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2025-10-06 | Option exercise 10b5-1 | +11,000 | $4.36 | $47,960 | 59,317 | D |
| Piscitelli Dominic Chief Financial Officer | 2025-10-06 | Sale 10b5-1 | −11,000 | $14.52 | $159,719 | 48,317 | D |
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2025-10-06 | Option exercise · Stock Option (right to buy) 10b5-1 | −11,000 | 196,500 | D | ||
| Open-market sales · 11,000 sh · avg $14.52 · $159,719 | |||||||
Loading xslF345X05/form4-10082025_091013.xml…